Send Message
Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
Email office@universeiol.com TEL: 86-0371-67897062-8008
Home
Home
>
news
>
Company news about Haohai Biological Technology acquires equity in Contamac
Events
LEAVE A MESSAGE

Haohai Biological Technology acquires equity in Contamac

2021-09-30

Latest company news about Haohai Biological Technology acquires equity in Contamac

On April 13, 2017, Haohai Healthcare Holdings (BVI) Co., Ltd. (the buyer), a wholly-owned subsidiary of Haohai Healthcare Holdings (BVI) Co., Ltd. (the buyer), entered into a share purchase agreement with the seller, pursuant to which the seller agreed to make a British company invisible 70% of the equity of the glasses and intraocular lens material manufacturing company was sold to the buyer for a consideration of 24.5 million pounds (equivalent to approximately HK$241 million).

 

Contamac Holdings Limited (the target company) is a limited liability company incorporated in the United Kingdom. It is mainly engaged in the manufacture of contact lenses and intraocular lens materials, including silicone hydrogel materials, breathable materials, hydrophilic lens materials, and hydrophobic and hydrophilic intraocular lenses Material.

 

The company said that the completion of the acquisition will help the group ensure a long-term and stable supplier of upstream intraocular lens materials and strengthen the research and development of new intraocular lens products. The Target Company has a good operating record in the manufacturing and distribution of intraocular lenses and contact lens materials. After the completion of the acquisition, the group will try to integrate the respective products, technologies, channels and other resources of the company and the target company to jointly develop the huge market potential of intraocular lens materials.

Contact Us at Any Time

86-0371-67897062-8008
Torch Building A, No. 8 Guohai Ave., Zhengzhou, Henan 450001, China
Send your inquiry directly to us